Abstract
Human peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal-recessive diseases caused by mutations in PEX genes that encode peroxins, proteins required for peroxisome biogenesis. These lethal diseases include Zellweger syndrome (ZS), neonatal adrenoleukodystro-phy (NALD) and infantile Refsum's disease (IRD)1, three pheno-types now thought to represent a continuum of clinical features that are most severe in ZS, milder in NALD and least severe in IRD2. At least eleven PBD complementation groups have been identified by somatic-cell hybridization analysis2–6 compared to the eighteen PEX complementation groups that have been found in yeast. We have cloned the human PEX1 gene encoding a 147-kD member of the AAA protein family (ATPases associated with diverse cellular activities)7, which is the putative orthologue of Saccharomyces cerevisiae Pexlp (ScPexlp). Human PEX1 has been identified by computer-based ‘homology probing’ using the ScPexlp sequence to screen databases of expressed sequence tags (dbEST) for human cDNA clones. Expression of PEX1 rescued the cells from the biogenesis defect in human fibroblasts of complementation group 1 (CG1), the largest PBD complementation group. We show that PEX1 is mutated in CG1 patie
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lazarow, P.B. & Moser, H.W. Disorders of peroxisome biogenesis.in The Metabolic and Molecular Bases of Inherited Disease, Vol. 2 (eds Scriver, C, Beaudet, A., Sly, W. & Valle, D.) 2287–2324 (McGraw-Hill, New York, 1995).
Moser, A.B. et al. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J. Pediatr. 127, 13–22 (1995).
Brul, S. et al. Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions: a study using complementation analysis. J. Gin. Invest. 81, 1710–1715 (1988).
Roscher, A.A. et al. Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis: a complementation study involving cell lines from 19 patients. Pediatr. Res. 26, 67–72 (1989).
Shimozawa, N. et al. Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defect. Am. J. Hum. Genet. 52, 843–844 (1993).
Poulos, A. et al. Peroxisomal assembly defects: clinical, pathologic, and biochemical findings in two patients in a newly identified complementation group. J. Pediatr. 127, 596–599 (1995).
Kunau, W.-H. et al.Two complementary approaches to study peroxisome biogenesis in Saccharomyces cerevisiae: forward and reversed genetics. Biochimie 75, 209–224 (1993).
Erdmann, R. et al. PAS1, a yeast gene required for peroxisome biogenesis, encodes a member of a novel family of putative ATPases. Cell 64, 499–510 (1991).
Heyman, J.A., Monosov, E. & Subramani, S. Role of the PAS1 gene of Pichia pastoris in peroxisome biogenesis. J. Cell Biol. 127, 1259–1273 (1994).
Confalonieri, F. & Duguet, M. A 200-amino acid ATPase module in search of a basic function. Bioessays 17, 639–650 (1995).
Beyer, A. Sequence analysis of the AAA protein family. Protein Sci. 6, 2043–2058 (1997).
Altschul, S.F., Gish, W., Miller, W., Myers, E.W. & Lipman, D.J. Basic local alignment search tool. J. Mol. Biol. 215, 403–410 (1990).
Kozak, M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44, 283–292 (1986).
Slawecki, M.L. et al Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders. J. Cell Sci. 108, 1817–1829 (1995).
Yahraus, T. et al. The peroxisome biogenesis disorder group 4 gene, PXAAA1 encodes a cytoplasmic ATPase required for stability of the PTS1 receptor. EMBO J. 15, 2914–2923 (1996).
Dodt, G. & Gould, S.J. Multiple PEX genes are required for proper subcellular distribution and stability of PexSp, the PTS1 receptor: evidence that PTS1 protein import is mediated by a cycling receptor. J. Cell Biol. 135, 1763–1774 (1996).
Weinstein, L. et al. Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc. Natl. Acad. Sci. USA. 87, 8287–8290 (1990).
Gärtner, J., Moser, H. & Valle, D. Mutations in the 70K peroxisomal membrane protein gene in Zellweger syndrome. Nature Genet. 1, 16–23 (1992).
Gärtner, J., Obie, C., Watkins, P. & Valle, D. Restoration of peroxisome biogenesis in a peroxisome-deficient mammalian cell line by expression of either the 35 kDa or the 70 kDa peroxisomal membrane proteins. J. Inher. Metab. Dis. 17, 327–329 (1994).
Dodt, G. et al.Mutations in the PTS1 receptor gene, PXR1,define complementation group 2 of the peroxisome biogenesis disorders. Nature Genet. 9, 115–125 (1995).
Braverman, N. et al. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nature Genet. 369–376 (1997).
Moser, H.W. et al. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts. Ann. Neurol. 7, 542–549 (1980).
Swinkels, B.W., Gould, S.J., Bodnar, A.G., Rachubinski, R.A. & Subramani, S. A novel, cleavable peroxisomal targeting signal at the amino-terminus of the rat 3-ketoacyl-CoAthiolase. EMBO J. 10, 3255–3262 (1991).
Chang, C.-C., Lee, W.-H., Moser, H., Valle, D. & Gould, S.J. Isolation of the human PEX12 gene, mutated in group3 of the peroxisome biogenesis disorders. Nature Genet. 15, 385–388 (1997).
Gould, S.J., Keller, G.-A. & Subramani, S. Identification of a peroxisomal targeting signal at the carboxy terminus of firefly luciferase. J. Cell Biol. 105, 2923–2931 (1987).
Miller, S.A., Dykes, D.D. & Polesky, H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Portsteffen, H., Beyer, A., Becker, E. et al. Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders. Nat Genet 17, 449–452 (1997). https://doi.org/10.1038/ng1297-449
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng1297-449
This article is cited by
-
A novel PEX1 mutation in a Moroccan family with Zellweger spectrum disorders
Human Genome Variation (2017)
-
SPATA5 mutations cause a distinct autosomal recessive phenotype of intellectual disability, hypotonia and hearing loss
Orphanet Journal of Rare Diseases (2016)
-
Characterization of two common 5' polymorphisms in PEX1 and correlation to survival in PEX1 peroxisome biogenesis disorder patients
BMC Medical Genetics (2011)
-
Initial sequencing and analysis of the human genome
Nature (2001)
